Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ultivis-9G
- Development stage
- Unknown
- Lead developer
- Grevis Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ultivis-9G is a multi-ingredient dietary supplement developed and marketed by Grevis Pharmaceuticals. It is formulated as soft gelatin capsules containing 37 essential nutrients, including Ginseng, Ginkgo biloba, Green Tea Extract, Grape seed Extract, Lycopene, Lutein, and Omega-3 fatty acids, alongside various vitamins, minerals, and antioxidants. The supplement is designed to support overall health, regulate antioxidant enzyme activity, provide neuroprotective and cardioprotective benefits, lower triglyceride levels, and protect eye health by reducing the risk of age-related macular degeneration and cataracts.
- Brand names
- Ultivis-9GUltivis9GUltivis 9G
- Other names
- Ultivis-9G Softgel CapsulesUltivis9G Softgel CapsulesUltivis 9G Softgel Capsules
Beyond the preview
Go deeper on Ultivis-9G.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ultivis-9G.